샘플 요청 목록

 카트 문의
시장보고서
상품코드
1571960

세계의 심장 보철 기기 시장

Cardiac Prosthetic Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 93 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심장 보철 기기 시장은 2030년까지 119억 달러에 도달할 전망입니다.

2023년에 74억 달러로 추정된 심장 보철 기기의 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 7.2%로 성장할 전망이며 2030년에는 119억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 이식형 페이스메이커는 복합 연간 성장률(CAGR) 7.7%로 성장을 지속하고, 분석 기간 종료 시 47억 달러에 달할 것으로 예측됩니다. 체외 맥박 조정기 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 6.8%로 추정됩니다.

미국 시장은 19억 달러, 중국은 복합 연간 성장률(CAGR) 10.7%로 성장할 것으로 예측됩니다.

미국의 심장 보철 기기 시장은 2023년 19억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 29억 달러 규모에 이를 것으로 예측되며 예측 기간 동안 복합 연간 성장률(CAGR)은 10.7%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 3.5%와 6.4%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 4.3%로 성장할 것으로 예측됩니다.

세계의 심장 보철 기기 시장 - 주요 동향과 촉진요인 정리

심장 보철이란 무엇이며 왜 심장 관리에 필수적인가?

심장 보조 장비는 심장 손상 또는 고장난 구성 요소를 지원하거나 교체하는 데 사용되는 의료용 임플란트이며 다양한 심장 질환을 가진 환자에게 구명 솔루션을 제공합니다. 이러한 장비는 심장 판막, 심박 조율기, 제세동기, 보조 인공 심장(VAD) 등을 포함하여 심장의 구조적 질환, 부정맥 및 심부전 관리에 매우 중요한 역할을합니다. 심혈관 질환(CVDs), 특히 심장 판막 장애와 심부전 세계의 이환율이 증가함에 따라, 심장 보조 장비는 현대 심장 병학에서 매우 중요합니다.

심장 판막 대체술은 가장 일반적으로 수행되는 심장 보철재 중 하나입니다. 밸브 협착이나 역류 등의 문제에 대해 결함이 있는 밸브를 기계적 또는 생물학적 대체품으로 대체함으로써 해결합니다. 심박 조율기 및 이식형 제세동기(ICD)와 같은 장비는 비정상적인 심장 리듬을 관리하는 데 도움이 되며 보조 인공 심장은 심장 이식을 기다리는 환자와 진행된 심부전 환자의 심장 기능을 지원합니다. 에 사용됩니다. 심혈관 질환은 여전히 세계의 사인의 최상이기 때문에 심장 보조 장비는 이환 환자의 QOL과 생존율을 향상시키는 데 필수적입니다.

기술의 발전은 심장 보철 기기 시장을 어떻게 형성하는가?

기술의 진보는 장비의 성능, 환자의 결과, 절차의 성공률을 향상시켜 심장 보철 시장에 혁명을 가져옵니다. 재료 과학의 혁신은 보다 내구성이 높고 생체적합성이 높은 심장 판막의 개발로 이어졌습니다. 예를 들어, 신형 기계식 밸브는 수명이 길게 설계되어 재수술의 필요성을 줄입니다. 한편, 생체 밸브는 동물 조직에서 유래한 것이 많고, 장기간의 혈액 희석제를 필요로 하지 않고, 응고 위험이 낮습니다. 또한, 경 카테터 대동맥 판막 치환술(TAVR)과 같은 경 카테터 심장 판막 치환술이 큰 지지를 얻고 있습니다. TAVR은 낮은 침습 수술로 개심술 없이 밸브 교체를 할 수 있어 회복 시간과 관련 위험을 줄일 수 있습니다. 리드레스페이스메이커는 작고 이식하기 쉽기 때문에 감염이나 기타 합병증의 위험이 적습니다. 마찬가지로 차세대 ICD는 생명을 위협하는 부정맥을 보다 정확하게 검출하고 치료하기 위한 프로그래밍을 강화하여 환자의 예후를 개선합니다. 게다가 보조 인공 심장의 진보로 이러한 장비는 더 작고 신뢰할 수 있으며, 진행된 심부전 환자의 관리가 용이해졌습니다. 원격 모니터링 및 무선 연결과 같은 디지털 건강 기술의 통합은 실시간으로 환자 모니터링, 장치 합병증의 조기 발견, 더 나은 이식 후 관리를 가능하게 하며 심장 보철 시장을 더욱 발전시키고 있습니다.

어떤 환자와 헬스케어 동향이 심장 보철 기기 수요를 견인하고 있는가?

일부 헬스케어 및 환자 동향은 심장 보철구 수요 증가를 촉진하고 있습니다. 노인은 심혈관 질환, 특히 심장 판막증과 심부전에 걸리기 쉽기 때문입니다. 평균 수명이 지속됨에 따라 심장 판막 대체술, 심박 조율기 및 기타 심장 장비에 대한 필요성도 커지고 있습니다. 또한, 선천성 심장 질환과 조기 발병의 심혈관 질환으로 진단 된 젊은 환자는 장기적인 해결책을 제공하는 보철기구의 진보의 혜택을 받고 있으며, 이러한기구는 다양한 연령대의 환자에게 매우 중요합니다.

또 다른 중요한 동향은 낮은 침습 수술에 대한 선호 증가입니다. 환자는 회복이 빠르고, 합병증이 적고, 입원 기간이 짧은 치료를 점점 요구하고 있습니다. TAVR, 경 카테터 승모판 성형술(TMVR), 저침습 페이스메이커 이식술 등의 기술은 이 수요에 부응하는 것으로, 더 많은 환자가 개심술과 관련된 위험 없이 구명 처치를 받을 수 있게 한다 있습니다. 이러한 절차를 더 많은 지역에서 사용할 수 있게 되면서 심장 보철 기기는 더 많은 사람들에게 쉽게 사용할 수 있습니다.

게다가, 환자 중심 케어에 대한 관심 증가와 디지털 건강의 상승이 수요에 영향을 미치고 있습니다. 환자와 헬스케어 제공업체는 원격 모니터링이 가능한 장치를 이용할 수 있게 되었으며, 보다 나은 치료 후 후속 조치 및 개별 관리가 가능해졌습니다. 이러한 진보는 만성 질환의 관리를 개선하고, 병원의 재입원을 줄이고, 환자의 만족도를 높이기 위해 심장 보철 기기 수요를 더욱 높여줍니다.

심장 보철 기기 시장의 성장은 여러 요인별로 이어진다

심장 보철 시장의 성장은 심혈관 질환의 유병률 증가, 노인 인구 증가, 의료 기술 진보 등 여러 요인에 의해 견인되고 있습니다. 주요 요인 중 하나는 특히 노인의 심장 판막 장애와 부정맥 발생률 증가입니다. 심장 판막증이 노화와 함께 흔해짐에 따라 기계적 및 생물학적 인공 심장 판막에 대한 수요가 증가하고 있습니다. TAVR과 같은 낮은 침습 수술은 위험이 낮고 회복 시간이 빠르면서 인기를 끌고 있으며 시장 확대에 크게 기여하고 있습니다.

기술의 발전도 성장을 가속하는 중요한 요소 중 하나입니다. 리드레스페이스메이커, 확장형 ICD, 소형 보조 인공 심장 등의 기술 혁신은 환자의 예후를 개선하고, 치료의 대상이 되는 환자의 범위를 확대하고 있습니다. 심장 보조 장비를 디지털 건강 도구와 통합하여 만성 심혈관 질환 환자의 실시간 모니터링과 더 나은 관리가 가능하며, 이러한 장치는 환자와 의료 제공업체 모두에게 더 효과적입니다. 매력적인 것입니다.

또한, 예방 헬스케어와 조기 진단에 대한 주목 증가로 종합적인 심혈관 케어 전략의 일환으로 심장 보철 기기의 채용이 증가하고 있습니다. 신흥국 시장에서의 헬스케어 인프라의 확대도 심장의 건강에 대한 의식의 고조와 함께 시장에 새로운 기회를 가져오고 있습니다. 세계 헬스케어 시스템이 심혈관 질환의 부담 증가에 임하고 있는 가운데 선진적이고 내구성이 뛰어나 환자 친화적인 심장 보철 기기 수요는 앞으로도 증가의 길을 따라갈 것으로 예상됩니다.

조사 대상 기업 예(총 42건)

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Labcor Laboratrios
  • Lepu Medical Technology Co,. Ltd.
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific
  • Shree Pacetronix
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical, Inc.
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.10.24

Global Cardiac Prosthetic Devices Market to Reach US$11.9 Billion by 2030

The global market for Cardiac Prosthetic Devices estimated at US$7.4 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Implantable Pacemakers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the External Pacemakers segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 10.7% CAGR

The Cardiac Prosthetic Devices market in the U.S. is estimated at US$1.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Cardiac Prosthetic Devices Market – Key Trends & Drivers Summarized

What Are Cardiac Prosthetic Devices, and Why Are They Crucial for Cardiac Care?

Cardiac prosthetic devices are medical implants used to support or replace damaged or failing components of the heart, offering life-saving solutions for patients with various heart conditions. These devices include heart valves, pacemakers, defibrillators, and ventricular assist devices (VADs), which play a pivotal role in managing structural heart diseases, arrhythmias, and heart failure. With the rising global incidence of cardiovascular diseases (CVDs), especially heart valve disorders and heart failure, cardiac prosthetic devices have become critical in modern cardiology.

Heart valve replacements are among the most commonly used cardiac prosthetic devices. They address issues like valve stenosis or regurgitation by replacing faulty valves with mechanical or biological alternatives. Devices like pacemakers and implantable cardioverter defibrillators (ICDs) help manage abnormal heart rhythms, while VADs are used to support heart function in patients awaiting heart transplants or for those with advanced heart failure. As cardiovascular disease remains the leading cause of death worldwide, cardiac prosthetic devices are essential for improving the quality of life and survival rates of affected patients.

How Are Technological Advancements Shaping the Cardiac Prosthetic Devices Market?

Technological advancements are revolutionizing the cardiac prosthetic devices market by improving device performance, patient outcomes, and procedural success rates. Innovations in materials science have led to the development of more durable and biocompatible heart valves. For instance, newer mechanical valves are designed to last a lifetime, reducing the need for repeat surgeries, while biological valves, often derived from animal tissue, offer a lower risk of clotting without requiring long-term blood thinners. Additionally, transcatheter heart valve replacement technologies, such as transcatheter aortic valve replacement (TAVR), have gained significant traction. TAVR is a minimally invasive procedure that allows valve replacement without the need for open-heart surgery, reducing recovery time and associated risks. Leadless pacemakers, which are smaller and easier to implant, offer less risk of infection and other complications. Similarly, next-generation ICDs come with enhanced programming to better detect and treat life-threatening arrhythmias, improving patient outcomes. Furthermore, advancements in VADs are making these devices more compact, reliable, and easier to manage for patients with advanced heart failure. The integration of digital health technologies, such as remote monitoring and wireless connectivity, is enabling real-time patient monitoring, early detection of device complications, and better post-implant care, further advancing the cardiac prosthetic devices market.

What Patient and Healthcare Trends Are Driving the Demand for Cardiac Prosthetic Devices?

Several healthcare and patient trends are driving the growing demand for cardiac prosthetic devices. The aging global population is one of the primary factors, as older individuals are more susceptible to cardiovascular diseases, particularly valvular heart diseases and heart failure. As life expectancy continues to rise, the need for heart valve replacements, pacemakers, and other cardiac devices is also increasing. Additionally, younger patients diagnosed with congenital heart defects or early-onset cardiovascular conditions are benefiting from advancements in prosthetic devices that offer long-term solutions, making these devices crucial for patients across various age groups.

Another significant trend is the rising preference for minimally invasive procedures. Patients are increasingly seeking treatments that offer quicker recovery times, fewer complications, and shorter hospital stays. Technologies like TAVR, transcatheter mitral valve repair (TMVR), and minimally invasive pacemaker implantation cater to this demand, enabling more patients to undergo life-saving procedures without the risks associated with open-heart surgery. The expanding availability of these procedures in more regions is making cardiac prosthetic devices accessible to a broader population.

Moreover, the growing focus on patient-centric care and the rise of digital health are influencing demand. Patients and healthcare providers now have access to devices that allow for remote monitoring, enabling better post-procedure follow-up and personalized care. These advancements improve the management of chronic conditions, reduce hospital readmissions, and enhance patient satisfaction, further driving demand for cardiac prosthetic devices.

Growth in the Cardiac Prosthetic Devices Market Is Driven by Several Factors

Growth in the cardiac prosthetic devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing aging population, and advancements in medical technologies. One of the key drivers is the increasing incidence of heart valve disorders and arrhythmias, particularly among older adults. As heart valve disease becomes more common with age, the demand for prosthetic heart valves, both mechanical and biological, is rising. Minimally invasive procedures like TAVR are gaining popularity due to their lower risks and faster recovery times, contributing significantly to market expansion.

Technological advancements are another crucial factor driving growth. Innovations such as leadless pacemakers, enhanced ICDs, and compact VADs are improving patient outcomes and expanding the range of patients eligible for treatment. The ability to integrate cardiac prosthetic devices with digital health tools is enabling real-time monitoring and better management of patients with chronic cardiovascular conditions, making these devices more effective and appealing to both patients and healthcare providers.

Additionally, the growing focus on preventive healthcare and early diagnosis is increasing the adoption of cardiac prosthetic devices as part of comprehensive cardiovascular care strategies. The expansion of healthcare infrastructure in developing regions, coupled with increased awareness about heart health, is also creating new opportunities for the market. As healthcare systems worldwide work to address the growing burden of cardiovascular diseases, the demand for advanced, durable, and patient-friendly cardiac prosthetic devices is expected to continue its upward trajectory.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Labcor Laboratrios
  • Lepu Medical Technology Co,. Ltd.
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific
  • Shree Pacetronix
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical, Inc.
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiac Prosthetic Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Material Science and Biocompatibility Enhance the Development of Cardiac Prosthetic Devices
    • Rising Global Prevalence of Heart Diseases Propels the Demand for Cardiac Prosthetics
    • Technological Innovations in Prosthetic Valves Improve Durability and Functional Outcomes
    • Increasing Adoption of Minimally Invasive Procedures Boosts Market Growth for Cardiac Prosthetics
    • Growth in Geriatric Population Worldwide Drives the Need for Advanced Cardiac Prosthetic Solutions
    • Expansion of Healthcare Infrastructure in Emerging Markets Opens New Opportunities for Cardiac Prosthetics
    • Patient-Specific Implants and Customization Using 3D Printing Technology Propel Market Innovations
    • Integration of Smart Sensors in Prosthetic Devices Enhances Post-Operative Monitoring and
    • Ethical and Legal Issues Surrounding the Use of Advanced Prosthetic Devices in Cardiology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiac Prosthetic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Implantable Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Implantable Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Implantable Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for External Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for External Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for External Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Cardiac Prosthetic Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Mechanical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cardiac Prosthetic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Spain 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Russia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of Europe 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Australia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: India 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: South Korea 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Cardiac Prosthetic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Argentina 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Brazil 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Mexico 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Cardiac Prosthetic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Iran 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Israel 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Saudi Arabia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UAE 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Africa 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제